We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+6.51%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.95B
AUM Growth
+$137M
Cap. Flow
+$63.5M
Cap. Flow %
3.26%
Top 10 Hldgs %
62.7%
Holding
375
New
57
Increased
197
Reduced
86
Closed
22

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$12.1M
2
AAPL icon
Apple
AAPL
+$11.7M
3
NVDA icon
NVIDIA
NVDA
+$9.16M
4
AVGO icon
Broadcom
AVGO
+$6.03M
5
PDD icon
Pinduoduo
PDD
+$5.45M

Top Sells

Rank Stock Value
1
ASX icon
ASE Group
ASX
+$18.3M
2
SE icon
Sea Limited
SE
+$11.3M
3
TSM icon
TSMC
TSM
+$9.27M
4
ZTO icon
ZTO Express
ZTO
+$7.08M
5
NIO icon
NIO
NIO
+$4.53M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 37.74%
2 Technology 30.94%
3 Communication Services 8.5%
4 Healthcare 6.31%
5 Financials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GFS icon
326
GlobalFoundries
GFS
$24.7B
$207K 0.01%
5,146
+431
+9% +$20K
PODD icon
327
Insulet
PODD
$10.1B
$207K 0.01%
+888
New +$182K
APGE icon
328
Apogee Therapeutics
APGE
$10.2B
$206K 0.01%
+3,506
New +$168K
MOH icon
329
Molina Healthcare
MOH
$10.5B
$206K 0.01%
+597
New +$197K
HSIC icon
330
Henry Schein
HSIC
$10B
$203K 0.01%
+2,789
New +$193K
VTRS icon
331
Viatris
VTRS
$18.9B
$202K 0.01%
17,426
-1,336
-7% -$15.4K
UHS icon
332
Universal Health Services
UHS
$10.1B
$202K 0.01%
+880
New +$190K
TFX icon
333
Teleflex
TFX
$5.94B
$201K 0.01%
+813
New +$190K
CTLT
334
DELISTED
CATALENT, INC.
CTLT
$201K 0.01%
+3,319
New +$196K
DVAX
335
DELISTED
Dynavax Technologies
DVAX
$188K 0.01%
16,856
-2,073
-11% -$22.9K
BCRX icon
336
BioCryst Pharmaceuticals
BCRX
$2.51B
$181K 0.01%
23,838
-4,447
-16% -$33.8K
ARQT icon
337
Arcutis Biotherapeutics
ARQT
$3B
$165K 0.01%
17,785
+2,026
+13% +$20K
MNKD icon
338
MannKind Corp
MNKD
$1.27B
$127K 0.01%
20,211
-1,068
-5% -$6.14K
IBRX icon
339
ImmunityBio
IBRX
$8.54B
$109K 0.01%
29,278
+2,820
+11% +$13.1K
IRWD icon
340
Ironwood Pharmaceuticals
IRWD
$682M
$105K 0.01%
25,485
+2,143
+9% +$11.5K
APLT
341
DELISTED
Applied Therapeutics
APLT
$87K ﹤0.01%
+10,232
New +$60.3K
HUMA icon
342
Humacyte
HUMA
$180M
$86.3K ﹤0.01%
+15,869
New +$105K
SANA icon
343
Sana Biotechnology
SANA
$1.18B
$85.7K ﹤0.01%
20,590
-85
-0.4% -$447
VIR icon
344
Vir Biotechnology
VIR
$1.84B
$83.7K ﹤0.01%
+11,170
New +$97K
RLAY icon
345
Relay Therapeutics
RLAY
$4.12B
$81.8K ﹤0.01%
11,550
-228
-2% -$1.7K
ANNX icon
346
Annexon
ANNX
$948M
$67.3K ﹤0.01%
+11,361
New +$67.4K
VERV
347
DELISTED
Verve Therapeutics
VERV
$65.6K ﹤0.01%
+13,554
New +$78.7K
ALT icon
348
Altimmune
ALT
$601M
$61.5K ﹤0.01%
10,010
-3,448
-26% -$23.4K
ALLO icon
349
Allogene Therapeutics
ALLO
$701M
$57K ﹤0.01%
20,363
-4,970
-20% -$13.2K
OCGN icon
350
Ocugen
OCGN
$451M
$50.8K ﹤0.01%
51,227
+2,815
+6% +$3.86K
11 12 13
14
15

Similar funds

ACM
Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $4.47B AUM 4.2% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
BP
BC Partners New York $4.43B AUM 49.12% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
AOI
Auto-Owners Insurance Lansing, Michigan $4.43B AUM 30.05% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

E Fund Management's Q3 2024 Portfolio in Review

As of Q3 2024, E Fund Management held 375 positions worth $1.95B, up 7.6% from $1.81B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

E Fund Management deployed $63.5M of net new capital in Q3 2024, opening 57 new positions and adding to 197 existing holdings. Its largest new stake was argenx: 5,800 shares worth $3.14M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 38% of assets, down from 40% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was TSMC, an estimated $9.27M trimmed.

  • E Fund Management's largest Q3 2024 buy was argenx: 5,800 shares worth $3.14M.
  • E Fund Management added most to Microsoft in Q3 2024, an estimated $12.1M increase.
  • E Fund Management's biggest Q3 2024 reduction was TSMC, cutting an estimated $9.27M.
  • E Fund Management fully exited ASE Group in Q3 2024, selling an estimated $18.3M.
  • E Fund Management's ten largest holdings make up 63% of its $1.95B portfolio in Q3 2024.
  • E Fund Management opened 57 new positions and closed 22 in Q3 2024.
  • E Fund Management's portfolio value rose 7.6% quarter-over-quarter to $1.95B.

Based on E Fund Management's 13F filing for Q3 2024, filed 13 Nov 2024.